• Profile
Close

Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy

Menopause Oct 30, 2018

Brinton LA, et al. - Researchers undertook this case-control study of breast cancer among women aged < 55 years—involving 1,031 patients and 919 population-control participants—to assess the effects on breast cancer risk of exposure to both oral contraceptives and menopausal hormones. Upon consideration of joint effects of the longer-term use of both agents, they noted a relative risk of 3.2 among participants who reported the use of oral contraceptives for ≥ 10 years and hormone replacement for ≥ 3 years vs non-users of either preparation. Despite the authors’ recommendation for caution in interpreting the results in view of small numbers within subgroups, findings revealed the necessity for further evaluation on breast cancer risk of the increasingly common exposure to both oral contraceptives and hormone replacement therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay